Who
Jackson P. Tai
Director
Company insider
Files Form 4 as: Director, Pony AI; Director, Eli Lilly and; Director, Mastercard; Director, NYSE Euronext.
In numbers
- Trades disclosed
- 91
- Buys
- 16
- Sells
- 0
- Bought
- $3.4M
- Sold
- $0
- Companies
- 4
- Companies where not an officer
- 4
- First trade
- 9 Sep 2008
- Last trade
- 14 Apr 2026
- Last filed
- 16 Apr 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 14 Apr 2026filed 16 Apr 2026 | PONY Pony AIoption or derivative · IT Services & Consulting | SEC FORM 4 Code A | —6,692 at $0.00 | filing |
| 14 Apr 2026filed 16 Apr 2026 | PONY Pony AIoption or derivative · IT Services & Consulting | SEC FORM 4 Code A | —6,692 at $0.00 | filing |
| 17 Apr 2023filed 19 Apr 2023 | LLY Eli Lilly andPharmaceuticals | SEC FORM 4 Code A | $1,8625 at $372.35 | filing |
| 20 Mar 2023filed 22 Mar 2023 | LLY Eli Lilly andPharmaceuticals | SEC FORM 4 Code A | $2,0026 at $333.60 | filing |
| 21 Feb 2023filed 22 Feb 2023 | LLY Eli Lilly andPharmaceuticals | SEC FORM 4 Code A | $1,9656 at $327.51 | filing |
| 17 Jan 2023filed 19 Jan 2023 | LLY Eli Lilly andPharmaceuticals | SEC FORM 4 Code A | $2,1466 at $357.74 | filing |
| 21 Nov 2022filed 22 Nov 2022 | LLY Eli Lilly andPharmaceuticals | SEC FORM 4 Code A | $180K498 at $361.17 | filing |
| 12 Aug 2022filed 16 Aug 2022 | LLY Eli Lilly andPharmaceuticals | SEC FORM 4 Bought | $200K656 at $304.19 | filing |
| 21 Jun 2022filed 23 Jun 2022 | MA MastercardPayments & Processors | SEC FORM 4 Code A | —741 at $0.00 | filing |
| 20 Dec 2021filed 22 Dec 2021 | LLY Eli Lilly andPharmaceuticals | SEC FORM 4 Code A | $2,1088 at $263.48 | filing |
| 15 Nov 2021filed 17 Nov 2021 | LLY Eli Lilly andPharmaceuticals | SEC FORM 4 Code A | $2,0678 at $258.43 | filing |
| 15 Nov 2021filed 17 Nov 2021 | LLY Eli Lilly andPharmaceuticals | SEC FORM 4 Code A | $175K677 at $258.43 | filing |
| 18 Oct 2021filed 20 Oct 2021 | LLY Eli Lilly andPharmaceuticals | SEC FORM 4 Code A | $1,9128 at $238.98 | filing |
| 20 Sep 2021filed 22 Sep 2021 | LLY Eli Lilly andPharmaceuticals | SEC FORM 4 Code A | $2,0859 at $231.64 | filing |
| 16 Aug 2021filed 17 Aug 2021 | LLY Eli Lilly andPharmaceuticals | SEC FORM 4 Code A | $1,8907 at $269.94 | filing |
| 19 Jul 2021filed 21 Jul 2021 | LLY Eli Lilly andPharmaceuticals | SEC FORM 4 Code A | $1,8738 at $234.14 | filing |
| 22 Jun 2021filed 24 Jun 2021 | MA MastercardPayments & Processors | SEC FORM 4 Code A | —622 at $0.00 | filing |
| 21 Jun 2021filed 23 Jun 2021 | LLY Eli Lilly andPharmaceuticals | SEC FORM 4 Code A | $2,0049 at $222.67 | filing |
| 17 May 2021filed 19 May 2021 | LLY Eli Lilly andPharmaceuticals | SEC FORM 4 Code A | $1,95510 at $195.53 | filing |
| 30 Apr 2021filed 3 May 2021 | LLY Eli Lilly andPharmaceuticals | SEC FORM 4 Bought | $150K820 at $182.74 | filing |
News
Polen Focus Growth Strategy Trims Eli Lilly and Company (LLY) While Maintaining Confidence in Its OutlookLLY · insidermonkey.com · 23 Oct 2026Eli Lilly's Growth Hasn't Slowed Progress As Sustainability LeaderLLY · investors.com · 23 Oct 2026Why this money manager is buying Apple, Eli Lilly and selling DollaramaLLY · theglobeandmail.com · 23 Oct 2026
0 headlines in the last 90 days name Jackson P. Tai; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.